4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000899243-22-037231
Chief Executive Officer acquired 195,906 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2022-11-28 | Grant or award | +195,906 | 220,906 | D |
Loading xslF345X03/doc4.xml…